Skip to main content
    P

    Puma Biotechnology Inc (PBYI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.14
    -0.20 (-2.72%)

    Market Cap: $379.47M

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Puma Biotechnology Inc (PBYI) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Puma Biotechnology (PBYI) has a latest price of $7.14 on Nov 17, 2026, 37.9% below its 52-week high of $11.50. Its price rose 46.0% over the past 12 months. The month-end price fell 72.7% over the 10 years through Oct 2026, a compound annual decline of 12.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $127.30 in Oct 2017 and its lowest $1.94 in May 2022, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PBYI with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PBYI.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 24.8%, and over 6 months it rose 4.8%. The month-end price rose 324.4% over the 3 years through Oct 2026, a compound annual rate of 61.9%.

    PeriodChange
    1 month-30.1%
    3 months-24.8%
    6 months+4.8%
    12 months+46.0%
    12 months, with dividends+46.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+324.4%+61.9%
    5 years+104.7%+15.4%
    10 years-72.7%-12.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 222.0%, and its weakest was 2018, when it fell 79.4%.

    YearCloseChange
    2026 through Oct 2026$10.44+75.5%
    2025$5.95+95.1%
    2024$3.05-29.6%
    2023$4.33+2.4%
    2022$4.23+39.1%
    2021$3.04-70.4%
    2020$10.26+17.3%
    2019$8.75-57.0%
    2018$20.35-79.4%
    2017$98.85+222.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 26.1% below its 50-day average of $9.66 and 11.2% below its 200-day average of $8.04.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$7.14
    52-week high$11.50-37.9%
    52-week low$4.79+48.9%
    50-day average$9.66-26.1%
    200-day average$8.04-11.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 69.6%.

    MeasureValue
    1-year beta0.99
    Largest fall, 1 year-36.6%
    Largest fall, 3 years-69.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Puma Biotechnology traded at 9.2x earnings at the end of 2025, against a 5-year median of 9.9x.

    PBYI valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PBYI

    What is PBYI's 1-year price change?

    Puma Biotechnology's price rose 46.0% over the past 12 months. With dividends included, the 12-month total return was 46.0%.

    What is PBYI's 5-year price change?

    Puma Biotechnology's month-end price rose 104.7% over the 5 years through Oct 2026, a compound annual rate of 15.4%. These figures leave out dividends.

    What is PBYI's 52-week high and low?

    Puma Biotechnology's 52-week high is $11.50 and its 52-week low is $4.79. Its latest price of $7.14 on Nov 17, 2026 is 37.9% below the high.

    What is PBYI's beta?

    Puma Biotechnology's 1-year beta against the S&P 500 is 0.99, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 36.6%.

    Is the PBYI chart free?

    Yes. Advanced Charting for PBYI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.